AWS for Health is a new effort highlighting AWS and AWS Partners’ services and solutions designed exclusively for healthcare, genomics, and biopharma.
FREMONT, CA: OKRA.ai, a provider of advanced AI solutions for pharmaceutical and life sciences executives, recently announced a partnership with Amazon Web Services’ (AWS) AWS for Health initiative to help rapidly upskill pharmaceutical companies looking to use technology to engage with physicians and reduce the costs of commercializing new treatments.
OKRA.ai CEO LoubnaBouarfa said, “We have built the most sophisticated AI brain for life sciences, with a range of AI applications that are empowering pharmaceutical staff to shorten the time to impact across critical parts of the value chain, including Value Access and Pricing, Medical Affairs and Commercial. OKRA.ai insights have been validated by several major pharmaceutical firms who are now enjoying the highest rates of internal engagement relative to any technology product in recent years, coupled with a ‘glass box promise’ that ensures OKRA.ai delivers transparency and explainability in every prediction and recommendation the system generates.”
AWS for Health is a new effort highlighting AWS and AWS Partners’ services and solutions designed exclusively for healthcare, genomics, and biopharma. Across the health communities, the project makes it easier for health customers to choose the best tools and partners for their highest-priority workloads. AWS for Health also acknowledges dedicated AWS Professional Services teams, AWS health industry professionals, and prominent AWS Partners in each solution area for clients wishing to speed deployments with solution-specific assistance.
Pharmaceutical corporations are adamant about using data from the entire healthcare industry to optimize engagement and scientific collaborations with healthcare providers. Healthcare Providers’ (HCPs) engagement patterns and preferences have advanced significantly in the last 18 months, and as new science emerges, it is vital to understand how to promote timely, meaningful engagements with HCPs where patients will benefit the most.
The process of providing value to physicians and patients has traditionally been inefficient, relying on inflexible regulations and limited data. On the other hand, life science companies have integrated massive volumes of data and made significant advances in interacting and communicating with clinicians, all while maintaining agility and scalability due to OKRA.ai’s commercial brain. The partnership between OKRA.ai and AWS enables businesses to deploy solutions rapidly, globally, and within their existing infrastructure.